Browse by UCL people
Group by: Type | Date
Number of items: 10.
Article
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
|
Cook, R;
Zoumpoulidou, G;
Luczynski, MT;
Rieger, S;
Moquet, J;
Spanswick, VJ;
Hartley, JA;
... Mittnacht, S; + view all
(2015)
Direct Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining.
Cell Rep
, 10
(12)
2006 - 2018.
10.1016/j.celrep.2015.02.059.
|
 |
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
|
Mandair, D;
Vesely, C;
Ensell, L;
Lowe, H;
Spanswick, V;
Hartley, JA;
Caplin, ME;
(2016)
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours.
Endocrine-Related Cancer
, 23
(10)
L29-L32.
10.1530/ERC-16-0201.
|
|
Puttick, Clare;
Jones, Thomas P;
Leung, Michelle M;
Galvez-Cancino, Felipe;
Liu, Jiali;
Varas-Godoy, Manuel;
Rowan, Andrew;
... Mcgranahan, Nicholas; + view all
(2024)
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Nature Genetics
, 56
(10)
pp. 2121-2131.
10.1038/s41588-024-01883-8.
|
 |
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2021)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/jco.21.00917.
(In press).
|
|
|
Spanswick, VJ;
Craddock, C;
Sekhar, M;
Mahendra, P;
Shankaranarayana, P;
Hughes, RG;
Hochhauser, D;
(2002)
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma.
BLOOD
, 100
(1)
224 - 229.
|
|
|
Spanswick, VJ;
Lowe, HL;
Newton, C;
Bingham, JP;
Bagnobianchi, A;
Kiakos, K;
Craddock, C;
... Hartley, JA; + view all
(2012)
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
BMC Cancer
, 12
, Article 436. 10.1186/1471-2407-12-436.
|
|
Poster
|
Forster, M;
Mendes, R;
Harrington, K;
Guerrero-Urbano, T;
Baines, H;
Spanswick, V;
Ensell, L;
... Beare, S; + view all
(2016)
A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC).
Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA.
|
